(19)
(11) EP 4 500 178 A1

(12)

(43) Date of publication:
05.02.2025 Bulletin 2025/06

(21) Application number: 24740635.8

(22) Date of filing: 15.05.2024
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
C12Q 1/6874(2018.01)
C12Q 1/6806(2018.01)
G01N 33/53(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/5005; G01N 33/53; G01N 2458/10; C12Q 1/6841; C12Q 1/6804
 
C-Sets:
  1. C12Q 1/6804, C12Q 2537/125, C12Q 2537/143, C12Q 2563/179, C12Q 2565/514;
  2. C12Q 1/6841, C12Q 2537/125, C12Q 2537/143, C12Q 2563/179, C12Q 2565/514;

(86) International application number:
PCT/US2024/029416
(87) International publication number:
WO 2024/238625 (21.11.2024 Gazette 2024/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.05.2023 US 202363502352 P

(71) Applicant: 10x Genomics, Inc.
Pleasanton, CA 94588-3260 (US)

(72) Inventors:
  • KAMATH, Govinda, M.
    Pleasanton, CA 94588-3260 (US)
  • WILLIAMS, Stephen, R.
    Pleasanton, CA 94588-3260 (US)

(74) Representative: Grund, Martin et al
Grund Intellectual Property Group Patentanwälte und Solicitor PartG mbB Steinsdorfstraße 2
80538 München
80538 München (DE)

   


(54) SPATIAL ANTIBODY DATA NORMALIZATION